First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
2018 · Journal of Translational Medicine · 528 citations
https://doi.org/10.1186/s12967-018-1507-6
S
Stacy D. D’Andre
WinnMed(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
1.4K
Citations
11
h-index
13
i10-index
Stacy D. D’Andre is an academic researcher from WinnMed. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer survivorship and care & Immunotherapy and Immune Responses. The author has an h-index of 11, co-authored 39 publications.
ORCID: 0000-0003-4726-7223Papers by this author
worksPertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With<i>ERBB2</i>Amplification or<i>ERBB2/3</i>Mutations: Results From the TAPUR Study
2022 · JCO Precision Oncology · 57 citations
https://doi.org/10.1200/po.22.00306
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
2018 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-018-1552-1
Weight-centric prevention of cancer
2024 · Obesity Pillars · 4 citations
https://doi.org/10.1016/j.obpill.2024.100106
Factors associated with and patterns of alcohol intake in late survivorship for breast cancer survivors
2026 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-8492613/v1
Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis
2026 · Supportive Care in Cancer · 0 citations
https://doi.org/10.1007/s00520-026-10452-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat